Stroke risk stratification in non-valvular atrial fibrillation
The CHA₂DS₂-VASc score estimates annual stroke risk in patients with non-valvular atrial fibrillation. Used to guide anticoagulation therapy decisions.
| Score | Annual Stroke Risk | Recommendation |
|---|---|---|
| 0 | 0.2% | No anticoagulation |
| 1 | 0.6% | Consider anticoagulation (men) |
| 2 | 2.2% | Anticoagulation recommended |
| 3 | 3.2% | Anticoagulation recommended |
| 4 | 4.0% | Anticoagulation recommended |
| 5 | 6.7% | Anticoagulation recommended |
| 6 | 9.8% | Anticoagulation recommended |
| 7 | 9.6% | Anticoagulation recommended |
| 8 | 6.7% | Anticoagulation recommended |
| 9 | 15.2% | Anticoagulation recommended |